trending Market Intelligence /marketintelligence/en/news-insights/trending/rPKzYflrUX4_yh7oFOQecw2 content esgSubNav
In This List

Intellia Therapeutics appoints president/CEO

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Intellia Therapeutics appoints president/CEO

John Leonard will become Intellia Therapeutics Inc.'s president and CEO on Jan. 1, 2018.

Leonard succeeds Nessan Bermingham, the company's founding president and CEO.

Leonard was most recently the executive vice president of research and development at the genome editing company.